Reacción #157979
ord-3792cd1e45f0486686d758298d99144c
Ecuación de reacción
Reactantes
Reactivos
Disolventes
Condiciones de reacción
Tratamiento posterior
- 1Temperaturaheating
- 2Otrowere performed at 200° C. for 60 minutes under microwave irradiation
- 3Otroto the reaction liquid
- 4Filtraciónthe resulting precipitate was collected by filtration
- 5Otrodried under reduced pressure
- 6workup.ADDITIONTFA was then added
- 7workup.STIRRINGstirring
- 8OtroThe reaction liquid
- 9Concentraciónwas concentrated under reduced pressure
- 10Otrothe residue was purified by silica gel column chromatography (MeOH/chloroform)
- 11OtroThe resulting crude purified matter
- 12workup.DISSOLUTIONwas dissolved in chloroform
- 13workup.ADDITIONa 4 M hydrochloric acid-EtOAc solution was then added
- 14workup.STIRRINGstirring
- 15workup.WAITwas performed at room temperature for 1 hour
- 16ConcentraciónThe solvent was concentrated under reduced pressure
Procedimiento
Tert-butyl[(4-methylpiperidin-4-yl)methyl]carbamate (343 mg), and DIPEA (348 μl) were added to an NMP (3 ml) solution of 11-chloro-2,3-dihydro-1H-cyclopenta[4,5]pyrido[1,2-a]benzimidazole-4-carboxamide (286 mg), and heating and stirring were performed at 200° C. for 60 minutes under microwave irradiation. After adding water to the reaction liquid, the resulting precipitate was collected by filtration and dried under reduced pressure. The resulting solid was suspended in chloroform, TFA was then added thereto and stirring was performed at room temperature for 1 hour. The reaction liquid was concentrated under reduced pressure and the residue was purified by silica gel column chromatography (MeOH/chloroform). The resulting crude purified matter was dissolved in chloroform, a 4 M hydrochloric acid-EtOAc solution was then added thereto and stirring was performed at room temperature for 1 hour. The solvent was concentrated under reduced pressure and the residue was solidified using EtOH/Et2O to obtain 11-[4-(aminomethyl)-4-methylpiperidin-1-yl]-2,3-dihydro-1H-cyclopenta[4,5]pyrido[1,2-a]benzimidazole-4-carboxamide dihydrochloride (177 mg).